2022
Treatment patterns and medical costs of metastatic breast cancer care in the United States.
Chehayeb R, Hood A, Mougalian S, Lustberg M, Wang S, Greenup R, Pusztai L, Kunst N. Treatment patterns and medical costs of metastatic breast cancer care in the United States. Journal Of Clinical Oncology 2022, 40: e18834-e18834. DOI: 10.1200/jco.2022.40.16_suppl.e18834.Peer-Reviewed Original ResearchMetastatic breast cancerTreatment patternsTreatment costsDiagnosis of MBCSocietal perspectiveHormone receptor statusBreast cancer careDays of diagnosisDe-identified databaseAverage wholesale priceElectronic health recordsMBC patientsMBC diagnosisReceptor statusCancer careInvasive cancerTriple NegativeClinical trialsReceptor subtypesPatient levelBreast cancerHuman epidermal growth factorPayer perspectiveDrug costsEpidermal growth factor
2017
The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database.
Campbell B, Thomas S, Ong C, Greenup R, Plichta J, Rosenberger L, Force J, Hyslop T, Hwang E, Fayanju O. The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database. Journal Of Clinical Oncology 2017, 35: 1570-1570. DOI: 10.1200/jco.2017.35.15_suppl.1570.Peer-Reviewed Original ResearchMetaplastic breast cancerNational Cancer DatabaseTriple-negative breast cancerMBC patientsBreast cancerMBC diagnosisReceptor statusCancer DatabaseAcademic centersSociodemographic factorsHigher clinical T stageFemale breast cancer patientsAdult female breast cancer patientsClinical T stageClinical N stageBreast cancer patientsMultivariate logistic regressionPopulation-based analysisCox proportional hazardsGovernment-sponsored insuranceNon-Hispanic blacksLow socioeconomic statusPaucity of dataOverall survivalWorse survivalA population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients.
Ong C, Thomas S, Campbell B, Greenup R, Plichta J, Rosenberger L, Force J, Hyslop T, Hwang E, Fayanju O. A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients. Journal Of Clinical Oncology 2017, 35: 532-532. DOI: 10.1200/jco.2017.35.15_suppl.532.Peer-Reviewed Original ResearchMetaplastic breast cancerMBC patientsOverall survivalWorse OSHigher clinical T stageMetaplastic breast cancer patientsCox proportional hazards modelNational Cancer DatabaseClinical T stageBreast cancer patientsPopulation-based analysisProportional hazards modelAxillary dissectionTN patientsReceptor statusTN subtypeAggressive variantHigher proportionLuminal subtypeT stageTreatment patternsEntire cohortKaplan-MeierCancer patientsSubgroup analysis